India, Feb. 16 -- A pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services has come into the spotlight after ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

XI'AN CITY, SHAANXI PROVINCE, CHINA, February 5, 2026 /EINPresswire.com/ -- The nutritional supplement industry is ...

GUANGZHOU CITY, GUANGDONG PROVINCE, CHINA, February 9, 2026 /EINPresswire.com/ -- The instant noodle industry continues ...

Results from the phase 2b PROCEED trial of intravenous bocunebart (also known as Lu AG09222) showed that the drug was able to ...

Neurocrine Biosciences, Inc. leverages a strong cash position and a neuropsychiatry pipeline to drive long-term commercial growth. See why NBIX stock is a buy.

The shortages come as malaria infections continue to rise across the province. In a separate memorandum issued the same day, Dhege also confirmed shortages of F75 and F100 therapeutic feeds — ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

New sublingual delivery system designed to provide more rapid relief from nausea caused by cancer medicines Ondansetron, currently sold under the brand name Zofran ®, was the 53rd most commonly ...

Opinion: Freedom-to-operate analysis must be understood as a continuous, integrated process that evolves alongside science, regulation, and commercial strategy.

In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming price cuts under the Inflation Reduction Act (IRA), AbbVie is the late | The ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...